Sarasin & Partners LLP Merck & Co., Inc. Transaction History
Sarasin & Partners LLP
- $10.2 Billion
- Q1 2024
A detailed history of Sarasin & Partners LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 2,808,147 shares of MRK stock, worth $348 Million. This represents 3.65% of its overall portfolio holdings.
Number of Shares
2,808,147
Previous 2,857,795
1.74%
Holding current value
$348 Million
Previous $312 Million
18.93%
% of portfolio
3.65%
Previous 3.43%
Shares
22 transactions
Others Institutions Holding MRK
# of Institutions
3,766Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.1 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$25.6 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.5 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.7 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$6.98 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $314B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...